The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 352:97 January 6, 2005 Number 1
NextNext

Production of Penicillin

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Lerner, P. I.
-PubMed Citation
To the Editor: Regarding Dr. Lerner's history of the production of penicillin (Aug. 5 issue)1, rarely has the development of a medical therapy occasioned such dedication and excitement. Charles Fletcher commented that "it is difficult to convey the excitement of actually witnessing the amazing power of penicillin over infections for which there had previously been no effective treatment."2 World War II was a major impetus for the crash program of penicillin production.3 This partnership of drug companies and the U.S. government set aside commercialism, patents, and antitrust law to encourage the sharing of information and know-how. The initial companies . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.